Document Classification

Section Type: RESULTS

Text: Using the intention-to-treat analysis, there were greater reductions in (mean [95 % CI]) HbA1c (-0. 70 [-1. 00 to -0. 39] vs. -0. 27 % [-0. 54 to 0] ; P = 0. 04), fasting plasma glucose (-0. 37 [-0. 75 to 0. 02] vs. 0. 41 mmol/l [-0. 08 to 0. 90] ; P = 0. 017) and 1-h plasma glucose (-0. 77 [-1. 44 to -0. 10] vs. 0. 65 mmol/l [-0. 07 to 1. 36] ; P = 0. 05) in the acarbose group compared with the placebo group.